Polycystic ovaries and ovarian hyperstimulation syndrome: A systematic review

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 7, 2005, Pages 611-616

  Tummon, Ian ^a   Gavrilova Jordan, Larisa ^a   Allemand, Michael C ^a   Session, Donna ^a,b  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Ovarian hyperstimulation syndrome; Polycystic ovaries; Systematic review; Ultrasonography

Indexed keywords

ALGORITHM; CASE CONTROL STUDY; COHORT ANALYSIS; CONFERENCE PAPER; CONFIDENCE INTERVAL; DATA BASE; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; MEDICAL LITERATURE; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; PUBLICATION; REPRODUCTIVE PROCEDURES; RISK FACTOR; SYSTEMATIC REVIEW;

FEMALE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 21444440928     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00788.x     Document Type: Conference Paper

References (25)

1. Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003; 9: 275-89.
2. Delvigne A, Demoulin A, Smitz J, Donnez J, Koninckx P, Dhont M et al. The Ovarian Hyperstimulation Syndrome in in-Vitro Fertilization - a Belgian Multicentric Study I. Clinical and Biological Features. Hum Reprod 1993; 8: 1353-60.
3. MacDougall MJ, Tan SL, Balen A, Jacobs HS. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 1993; 8: 233-7.
4. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.
5. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-7.
6. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A et al. (ed). Polycystic Ovary Syndrome. Boston: Blackwell Scientific 1992, 377-84.
7. Al-Ramahi M. Severe OHSS: decreasing the risk of severe ovarian hyperstimulation syndrome. Hum Reprod 1999; 14: 2421-2.
8. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002; 8: 559-77.
9. Wong IL, Morris RS, Lobo RA, Paulson RJ, Sauer MV. Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation. Hum Reprod 1995; 10: 524-8.
10. Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV Jr. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994; 9: 792-9.
11. Reljic M, Vlaisavljevic V, Gavric V, Kovacic B. Number of oocytes retrieved and resulting pregnancy. Risk factors for ovarian hyperstimulation syndrome. J Reprod Med 1999; 44: 713-8.
12. Morris RS, Paulson RJ, Sauer MV, Lobo RA. Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum Reprod 1995; 10: 811-4.
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. [see comment]. BMJ 1997; 315: 629-34.
14. Aboulghar MA, Mansour RT, Serour GI, Ramzy AM, Amin YM. Oocyte quality in patients with severe ovarian hyperstimulation syndrome. Fertil Steril 1997; 68: 1017-21.
15. Danninger B, Brunner M, Obruca A, Feichtinger W. Prediction of ovarian hyperstimulation syndrome of baseline ovarian volume prior to stimulation. Hum Reprod 1996; 11: 1597-9.
16. Dew JE, Don RA, Hughes GJ, Johnson TC, Steigrad SJ. The significance of pelvic ultrasound abnormalities detected on routine ultrasound scanning prior to assisted reproduction. Int J Fertil Womens Med 1998; 43: 150-4.
17. Dor J, Ben-Shlomo I, Lipitz S, Levran D, Etchin A, Rudak E et al. Ovarian stimulation with gonadotropin-releasing hormone (GnRH) analogue improves the in vitro fertilization (IVF) pregnancy rate with both transvaginal and laparoscopic oocyte recovery. J In Vitro Pert Embryo Transf 1990; 7: 351-4.
18. Engmann L, Maconochie N, Sladkevicius P, Bekir J, Campbell S, Tan SL. The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod 1999; 14: 167-71.
19. Enskog A, Henriksson M, Unander M, Nilsson L, Brannstrom M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1999; 71: 808-14.
20. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000; 73: 901-7.
21. Wada I, Matson PL, Troup SA, Lieberman BA. Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome. Br J Obstet Gynaecol 1993; 100: 365-9.
22. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985; 2: 1375-9.
23. Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978; 30: 255-68.
24. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989; 44: 430-40.
25. WHO. Agents stimulating gonadal function in the human. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1973; 514: 1-30.